What is Quercetin?

Quercetin, a flavonoid abundantly found in various fruits, vegetables, and grains, has garnered attention for its remarkable antioxidant properties. It belongs to the polyphenol group of compounds, known for their ability to neutralize free radicals. Free radicals are unstable molecules that can cause cellular damage and contribute to various health issues, including aging and chronic diseases.

What does Quercetin IV therapy do?

Thanks to its antioxidant properties, this therapy aids in tackling various conditions linked to oxidative stress, including allergies, cancer support, neurodegenerative diseases, metabolic syndrome, and type 2 diabetes. In addition to its antioxidant properties, Quercetin exhibits potent anti-inflammatory effects. This makes it a valuable option for the treatment of inflammatory conditions like arthritis and asthma. Furthermore, Quercetin has been linked to improved cardiovascular health by reducing blood pressure, cholesterol levels, and the risk of atherosclerosis. Administering Quercetin intravenously ensures better absorption and quicker effects compared to oral intake.

Are there side effects?

Quercetin is generally well tolerated. Some individuals may experience minor discomfort such as an upset stomach or headache during infusion. It’s essential to consult a healthcare provider regarding potential side effects and personal risks before starting any treatment.

How long does the infusion take?

The infusion time varies based on dosage, typically lasting between 60 to 120 minutes.

Who can get IV Quercetin?

In summary, IV Quercetin therapy offers a holistic approach to promoting overall health and well-being. This is true particularly for individuals grappling with chronic conditions associated with inflammation, oxidative stress, or compromised immune function. Consult one of our qualified naturopathic doctors or your healthcare provider to see if the therapy might be right for you.

 

References:

HJ;, G. R. M. (n.d.). Disposition of Quercetin in man after single oral and intravenous doses. European journal of clinical pharmacology. https://pubmed.ncbi.nlm.nih.gov/1233267/